-
Dans une version accessible au plus grand nombre
-
Une avancée qui pourrait ouvrir la voie à la production…
-
Il succède au professeur José-Alain Sahel.
-
lauréat de l'appel à projets Biocluster France…
-
Restaurer la vision grâce à une thérapie…
-
Observer et manipuler l’activité d’un circuit…
-
Projet européen coordonné par Filippo del Bene…
-
on cone phoreceptors damage driven by light
-
for stem cell engineering
-
for subcellular and cell specific calcium manipulation
-
to investigate the functioning of the visual cortex
-
Observer et manipuler l’activité d’un circuit…
-
Dans une version accessible au plus grand nombre
Companies & Industries
The Group stepped up its commitment to ophthalmology on March 23, 2011 when Christopher A. Viehbacher, CEO of sanofi-aventis, and Professor José-Alain Sahel, Director of the Institut de la Vision, signed a framework agreement for a period of three years.
Companies & Industries
Essilor, the world’s leading ophthalmic optics company
From design to manufacture, the group develops a wide range of lenses to correct and protect eyesight. Its mission is to enable everyone in the world to see well using lenses tailored to their needs. Essilor also develops and sells equipment for prescription laboratories as well as instruments and services designed for optical professionals.
Horus Pharma expands at the "Institut de la Vision" in Paris and joins one of the major European centers of research in ophthalmology.
Théa is an independent pharmaceutical company specialized in the research, development and commercialization of eye-care products.
Iris Pharma Specializes in Offering Preclinical and Clinical Ophthalmology Research Services Worldwide.
More than 10 research facilities are at the core of the Institute’s research activities
Read more...